BR112022005345A2 - Composições imunogênicas - Google Patents
Composições imunogênicasInfo
- Publication number
- BR112022005345A2 BR112022005345A2 BR112022005345A BR112022005345A BR112022005345A2 BR 112022005345 A2 BR112022005345 A2 BR 112022005345A2 BR 112022005345 A BR112022005345 A BR 112022005345A BR 112022005345 A BR112022005345 A BR 112022005345A BR 112022005345 A2 BR112022005345 A2 BR 112022005345A2
- Authority
- BR
- Brazil
- Prior art keywords
- immunogenic compositions
- field
- vaccines
- bacteria
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19200878.7A EP3799884A1 (en) | 2019-10-01 | 2019-10-01 | Immunogenic compositions |
| PCT/EP2020/077416 WO2021064050A1 (en) | 2019-10-01 | 2020-09-30 | Immunogenic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022005345A2 true BR112022005345A2 (pt) | 2023-04-25 |
Family
ID=68136165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022005345A BR112022005345A2 (pt) | 2019-10-01 | 2020-09-30 | Composições imunogênicas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220339277A1 (https=) |
| EP (2) | EP3799884A1 (https=) |
| JP (1) | JP7650871B2 (https=) |
| KR (1) | KR20220070279A (https=) |
| CN (1) | CN114502193A (https=) |
| AU (1) | AU2020358775B2 (https=) |
| BR (1) | BR112022005345A2 (https=) |
| CA (1) | CA3156017A1 (https=) |
| IL (1) | IL291559A (https=) |
| MX (1) | MX2022003871A (https=) |
| WO (1) | WO2021064050A1 (https=) |
| ZA (1) | ZA202203363B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250263447A1 (en) * | 2020-09-04 | 2025-08-21 | Intravacc B.V. | Ompa mutations enhance omv production in bordetella pertussis |
| GB202211033D0 (en) | 2022-07-28 | 2022-09-14 | Glaxosmithkline Biologicals Sa | Purification process |
| CN117417419B (zh) * | 2023-01-10 | 2024-04-19 | 康希诺生物股份公司 | 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5388E (fr) | 1905-06-08 | 1906-03-27 | Jean Eugene Gabillon | Radiateur à grand pouvoir refroidissant pour automobiles |
| US4057685A (en) | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
| DE2848965A1 (de) | 1978-11-11 | 1980-05-22 | Behringwerke Ag | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
| US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| US4663160A (en) | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
| US4761283A (en) | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
| US4695624A (en) | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
| US4882317A (en) | 1984-05-10 | 1989-11-21 | Merck & Co., Inc. | Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency |
| US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
| IT1187753B (it) | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
| NL8802046A (nl) | 1988-08-18 | 1990-03-16 | Gen Electric | Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen. |
| ATE127347T1 (de) | 1989-04-28 | 1995-09-15 | Sclavo Spa | Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis. |
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| CA2138997C (en) | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| WO1995008348A1 (en) | 1993-09-22 | 1995-03-30 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| TR199701547T1 (xx) | 1995-06-07 | 1998-03-21 | Smithkline Beecham Biologicals S.A. | Polisakarit antijen protein e�leni�i i�eren a��. |
| US6558677B2 (en) | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| ES2301181T3 (es) * | 1997-08-21 | 2008-06-16 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Mutantes nuevos de bacterias mucosas gram negativas y su aplicacion en vacunas. |
| DE69941574D1 (de) | 1998-08-19 | 2009-12-03 | Baxter Healthcare Sa | Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid |
| AU2001294750C1 (en) | 2000-09-26 | 2008-09-18 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| AU2002306849A1 (en) * | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
| JPWO2003050782A1 (ja) | 2001-12-12 | 2005-04-21 | 株式会社法学館 | 演習問題出題システム |
| GB0202901D0 (en) | 2002-02-07 | 2002-03-27 | Glaxosmithkline Biolog Sa | Novel vaccine |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| GB0424092D0 (en) * | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| GB0522765D0 (en) | 2005-11-08 | 2005-12-14 | Chiron Srl | Combination vaccine manufacture |
| JP5814507B2 (ja) | 2006-09-07 | 2015-11-17 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
| EP2820133B1 (en) | 2012-02-28 | 2017-08-02 | The Board of Regents of The University of Texas System | Synthetic lipid biology for combinatorial engineering of endotoxin |
| PL404247A1 (pl) * | 2013-06-07 | 2014-12-08 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością | Koniugat oligocukru LOS Bordetella pertussis i toksyny krztuśca i jego zastosowanie w profilaktyce i leczeniu zakażeń wywoływanych przez Bordetella pertussis |
| WO2015179270A2 (en) | 2014-05-19 | 2015-11-26 | Board Of Regents, The University Of Texas System | Combinatorial platform for the display of surface adjuvants and antigens |
| KR102549847B1 (ko) | 2016-07-28 | 2023-06-29 | 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. | 헤모필루스 인플루엔자 타입 b에 대항하는 백신으로서 안정한 가수분해-내성 합성 폴리리보실리비톨포스페이트 유도체 |
| ES2992907T3 (en) * | 2017-03-13 | 2024-12-19 | Intravacc B V | Bordetella vaccines comprising lps with reduced reactogenicity |
| KR102822764B1 (ko) * | 2017-12-04 | 2025-06-19 | 인트라백 비.브이. | 외막 소포의 생성을 위한 개선된 방법 |
-
2019
- 2019-10-01 EP EP19200878.7A patent/EP3799884A1/en not_active Ceased
-
2020
- 2020-09-30 US US17/763,354 patent/US20220339277A1/en active Pending
- 2020-09-30 CN CN202080069731.5A patent/CN114502193A/zh active Pending
- 2020-09-30 BR BR112022005345A patent/BR112022005345A2/pt unknown
- 2020-09-30 EP EP20776213.9A patent/EP4038090A1/en active Pending
- 2020-09-30 WO PCT/EP2020/077416 patent/WO2021064050A1/en not_active Ceased
- 2020-09-30 AU AU2020358775A patent/AU2020358775B2/en active Active
- 2020-09-30 CA CA3156017A patent/CA3156017A1/en active Pending
- 2020-09-30 JP JP2022520197A patent/JP7650871B2/ja active Active
- 2020-09-30 KR KR1020227014156A patent/KR20220070279A/ko active Pending
- 2020-09-30 MX MX2022003871A patent/MX2022003871A/es unknown
-
2022
- 2022-03-21 IL IL291559A patent/IL291559A/en unknown
- 2022-03-22 ZA ZA2022/03363A patent/ZA202203363B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN114502193A (zh) | 2022-05-13 |
| ZA202203363B (en) | 2026-02-25 |
| EP4038090A1 (en) | 2022-08-10 |
| KR20220070279A (ko) | 2022-05-30 |
| JP7650871B2 (ja) | 2025-03-25 |
| US20220339277A1 (en) | 2022-10-27 |
| MX2022003871A (es) | 2022-06-02 |
| EP3799884A1 (en) | 2021-04-07 |
| AU2020358775B2 (en) | 2025-04-17 |
| WO2021064050A1 (en) | 2021-04-08 |
| JP2022550560A (ja) | 2022-12-02 |
| IL291559A (en) | 2022-05-01 |
| AU2020358775A1 (en) | 2022-04-14 |
| CA3156017A1 (en) | 2021-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018077266A2 (pt) | composições compreendendo cepas bacterianas | |
| WO2020120714A8 (en) | Compositions comprising bacterial strains | |
| PH12019500360A1 (en) | Antibiotic compounds | |
| MX2018003101A (es) | Activo de polipeptidos de lisina contra bacterias gram-negativas. | |
| MX2020012061A (es) | Composiciones que comprenden cepas bacterianas. | |
| PH12016501577B1 (en) | Monobactam organic compounds for the treatment of bacterial infections | |
| ZA202002093B (en) | Antibacterial compounds | |
| MX2018001075A (es) | Agentes terapeuticos y profilacticos antibacterianos. | |
| CL2011002639A1 (es) | Cepa bacteriana de mycoplasma bovis atenuada avirulenta; composicion inmunogenica que la comprende; y uso para fabricar un medicamento para infecciones producidas por m. bovis. | |
| ZA202203363B (en) | Immunogenic compositions | |
| EP4241851A3 (en) | Immunogenic compositions | |
| UY31437A1 (es) | Vacuna de mycoplasma bovis y métodos de uso de la misma | |
| PH12016501988A1 (en) | Antibacterial compounds | |
| MX389771B (es) | Compuestos de minociclina para biodefensas. | |
| MX2017009094A (es) | Derivado de polimixina y usos del mismo. | |
| PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
| HK1243951A1 (zh) | 抗微生物组合和其在治疗微生物感染中的用途 | |
| MX382439B (es) | Compuestos de carbapenem | |
| BR112019002023A2 (pt) | prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas | |
| MX2019006086A (es) | Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados. | |
| MX373098B (es) | Derivados de manosa para tratar infecciones bacterianas. | |
| WO2020120716A8 (en) | Compositions comprising bacterial strains | |
| WO2017140683A3 (en) | Streptococcus uberis extract as an immunogenic agent | |
| WO2021028700A3 (en) | Bacterial compositions for the treatment of disease | |
| BR112017022796A2 (pt) | composições antibacterianas e métodos |